 Home > Medical News > Latest Medical News > Xinhua Pharmaceutical Clindamycin Phosphate Injection Passed the Consistency Evaluation of Generic Drugs

Xinhua Pharmaceutical Clindamycin Phosphate Injection Passed the Consistency Evaluation of Generic Drugs

 Last Update: 2021-10-20
 Source: Internet
 Author: User

Tags

antabuse side effects

bulk medical supplies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 13, Xinhua Pharmaceutical issued an announcement stating that the company received the Clindamycin Phosphate Injection (2ml: 0.

Clindamycin Phosphate Injection was developed by PHARMACIA AND DUPJOHN CO and listed in the United States under the trade name Cleocin Phosphate®

In October 2020, Xinhua Pharmaceutical submitted Clindamycin Phosphate Injection (2ml:0.

Up to now, Shandong Xinhua Pharmaceutical Co.

As of the date of this announcement, the company has invested approximately RMB 9.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.